









| Catalog No. | HB782146 |
|---|---|
| Description |
Inezetamab (HB782146) is a research-grade recombinant antibody targeting CD40. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Human |
| Isotype | IgG1-lambda2-[scFv-heavy-kappa]2 |
| Expression system | Mammalian cells |
| Clonality | Monoclonal |
| Tested applications | WB |
| Target | Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, TNFRSF5, CDw40, CD40, CAK1 antigen, Mesothelin, MSLN, Pre-pro-megakaryocyte-potentiating factor, MPF |
| Endotoxin level | < 10 EU/mg |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P25942 & Q13421 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | Bispecifictetravalent, AMG994, AMG-994, AMG994, 2568264-76-4 |
| Background | Inezetamab is a bispecific anti-CD40 and anti-MSLN IgG1 monoclonal antibody. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Inezetamab.

Detects recombinant MSLN (Catalog No: HC496012) in indirect ELISA.

Detects recombinant CD40 (Catalog No: HB782011) in indirect ELISA.

Detects recombinant MSLN (Catalog No: HC496021) in indirect ELISA.

Lane 1: recombinant human MSLN (Catalog No: HC496012)
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com










+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский